AIOS Tech Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data AIOS Tech Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	27.1	29.2	25.3	2.53	42.2	160	234	387	340	5.07
Cost of revenue	16.2	18.1	17.5	12.9	19.7	67.6	197	347	309	1.42
Gross profit	10.5	10.4	7.58	2.51	22.2	54	37	40	30.9	3.65
Research and development	0.03	0.51	0.92	0.16	0.82	1.6	1.56	0.47	9.95	2.18
General and administrative	0.93	3.68	1.17	1.08	8.19	11.6	10.5	10.9	19.2
Operating expenses	2.48	6.57	2.09	1.33	12.2	15.9	19.3	0.47	9.95	2.18
Operating income	7.98	3.88	-2.09	1.17	10	38.2	17.7	-0.47	-9.95	1.47
Interest expense	0.05	0.06	0.21	0.16		0.03	0.02	0.13	0.1
Interest income							2.79	2.56	1.66
Other non-operating income	-0.04	0.32	-0.47	0	0.04	0	4.81	-0.07	0.1	-225
Pre-tax income	7.94	4.2	-2.09	1.18	10.9	40.8	22.5	-0.54	-9.86	-224
Income tax	2	-2.94	-0.65	-0.06	0.94	10.3	4.74	5.82	4.53	0.07
Income from continuing operations			-2.09	1.23	9.92	30.5	17.8	-0.54	-9.86	-224
Net income to minority interests					0.04	0.13	0.16	0.13	0.11
Net income	5.93	7.14	-5.14	2.74	-13.1	30.4	17.6	17.6	5.79	-221
EBITDA	8.5	4.82	-0.9	1.42	11.7	40.4	19.8	1.77	-8.23	3.09
EPS, basic	4.86	4.86	-3.27	1.69	-7.04	14.13	4.42	4.46	1.43	-47.65
EPS, diluted	4.86	4.86	-3.27	1.69	-7.04	14.13	4.42	4.46	1.43	-47.65
Shares, basic (weighted)	1.21	1.48	1.59	1.64	1.86	2.15	3.99	3.94	4.05	4.64
Shares, diluted (weighted)	1.21	1.48	1.59	1.64	1.86	2.15	3.99	3.94	4.05	4.64

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	11.9	3.22	0.95	2.76	22.1	91.4	63.9	114	6.11	1.41
Short-term investments					4.68	40.7	11.7	12.8	6.88	0
Receivables	0.19	1.42	2.66	1.23	4.94	18.5	18.9	21.1	54.4	1.58
Inventory	2.25	1.58	0.37	0.64	5.02	18.6	31.6	31	0.81
Other current assets	4.54	11.9	3.57	2.53			10.9	16	25.9	2.05
Total current assets	34.6	38.6	35.3	52.9	60.4	228	231	293	251	5.04
Property, plant and equipment	11.2	14.6	12.5	0.29	0.66	0.46	0.72	0.88	0.36
Lease right-of-use assets				1.92			3.35	2.38	1.61
Goodwill				11.1	25.2	25.8	23.8	17.7	17.1
Intangible assets	1.07	1.09	0.97	4.19	3.73	2.85	1.8	0.88	0.21	0.05
Long-term investments					15.7	16.2	7.25
Total assets	47.1	54.5	56.7	94	108	274	283	316	271	5.1
Accounts payable	1.19	1.28	1.36	0.22	1.31	35	40.9	45.5	34.6
Deferred revenue	1.04						21.8	38.2	7.53
Short-term debt	0.29	0.46	-1.7	0.86		0.78	0.43	1.97	5.27
Total current liabilities	15.4	13.2	19.7	37.4	26.8	88.7	90.5	111	59.5	0.41
Long-term debt	0.53	0.41		1.77			0.43
Lease liabilities				0.37	0.68	0.15	2.43	1.64	0.82
Total liabilities	15.9	14	19.9	40.1	28.2	89.4	93.6	113	60.3	0.41
Total debt	0.82	0.87	1.7	1.77			0.43
Paid-in capital	10.2	10.2	13.4	28.4	59.5	130	131	131	140	141
Retained earnings	22.7	29.9	24.7	27.5	9.63	37.8	53.2	68.4	72.5	-135
Treasury stock							-0.36	-0.26	-1.25	-1.47
Other comprehensive income	-1.85	0.4	-1.35	-1.91	3.59
Shareholders' equity	31.1	40.5	36.8	53.9	76.8		186	199	207	4.69
Minority interests				-0.01	3.09	3.97	4.17	4.26	4.37
Total equity	31.1	40.5	36.8	53.9	79.9	185	190	203	211	4.69
Total liabilities and equity	47.1	54.5	56.7	94	108	274	283	316	271	5.1
Shares outstanding	1.48	1.48

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	5.93	7.14	-5.14	2.74	-13.1	30.5	17.8	17.7	5.9	-221
Depreciation and amortization	0.52	0.94	1.2	0.24	1.69	2.18	2.11	2.24	1.72	1.62
Stock-based compensation					1.1	0.5	0.13
Deferred income tax	0.06	0.01	-1.47	-0.06	-0.58	0.28	0.27	-0.71	-0.12
Change in receivables	0.92	-0.95	-1.38	-0.82	0.57	-13.3	-2.08	-3.09	-34.6	19.2
Change in inventory	0.43	0.79	1.18	-0.28		-3.93	-25.5	-0.25	29.8	-6.91
Change in payables	-0.29	0.03	0.15	0.82
Cash from operations	1.58	-6.1	-0.73	0.34	2.69	23.9	-29	35.5	-75.7	-26.9
Capital expenditures	-0.01	-3.13	-0.07	-0.24	-0.2	-0.19	-0.65	-0.5	-0.03
Acquisitions				2.04	4.99	-7.01	-0.53
Purchases of investments					-3.07	-39.5	-51.6	-104	-39.1
Sales and maturities of investments								14.4
Cash from investing	-0.98	-3.13	-0.12	-1.96	-4.72	-25.3	17.8	-87.2	-32.9	-14.5
Debt issued	0.56	0.17
Debt repaid		-0.05					-41.5	-8.03
Stock issued	10.1					70.8
Share buybacks							-0.36
Cash from financing	10.3	0.92	0.73	3.15	18.4	70.5	-8.34	-6.75	-0.74	0.7
Exchange rate effect	-0.1	-0.29	-0.09	-0.18	2.81	0.29	-4.85
Net change in cash	10.8	-8.6	-0.2	1.34	19.1	69.4	-24.3
Free cash flow	1.57	-9.22	-0.8	0.1	2.48	23.7	-29.6	35	-75.7
Interest paid	0.05	0.08	0.09	0.15	0.12	0.37	0.5	0.03	0.17	0.08
Income taxes paid			0.04	0.01	0.55	5.55	10.4	4.53	5.67	1.61

Key metrics

Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $12.50 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	72.0%	Gross profit / revenue.
Operating margin	29.0%	Operating income / revenue.
EBITDA margin	61.0%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-4,413.0%	Pre-tax income / revenue.
Net margin	-4,359.0%	Net income / revenue.
Operating cash flow margin	-530.4%	Cash from operations / revenue.
Return on equity (ROE)	-208.9%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-159.8%	Net income / average total assets.
Return on invested capital (ROIC)	1.1%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	42.9%	Research and development expense / revenue.
D&A / revenue	32.0%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-98.5%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-72.1%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-34.5%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-88.2%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-53.8%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-30.3%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income CAGR, 3y	-56.4%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	-31.9%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA CAGR, 3y	-46.2%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-23.4%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-3,917.0%	Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y	-3,432.0%	EPS vs the same period a year earlier. Only from a positive base.
Book value growth, 1y	-97.7%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-70.7%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-42.8%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-98.1%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-73.8%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-45.7%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	14.4%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	5.2%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	20.1%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	12.3x	Current assets / current liabilities.
Quick ratio	7.28x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	3.44x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	8.1%	Total liabilities / total assets.
Working capital	$4.6M	Current assets - current liabilities.
Goodwill and intangibles / assets	1.1%	(Goodwill + intangible assets) / total assets.
Tangible book value	$4.6M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.04x	Revenue / average total assets.
Receivables turnover	0.18x	Revenue / average receivables.
Days sales outstanding	2,018 days	365 x average receivables / revenue.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$47.65	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	-$47.65	Net income per basic share, as reported (split-adjusted).
Revenue per share	$1.09	Revenue / diluted weighted shares.
Operating cash flow per share	-$5.80	Cash from operations / diluted weighted shares.
Book value per share	$1.01	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$1.00	Tangible book value / shares outstanding.
Cash per share	$0.30	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$40.6M	Share price x shares outstanding.
Enterprise value	$39.2M	Market cap + total debt - cash - short-term investments.
P/S	8.01x	Market cap / revenue.
P/B	8.67x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	8.77x	Market cap / tangible book value, when positive.
EV/Sales	7.74x	Enterprise value / revenue.
EV/EBIT	26.6x	Enterprise value / operating income, when both are positive.
EV/EBITDA	12.7x	Enterprise value / EBITDA, when both are positive.
Earnings yield	-543.9%	Net income / market cap (the inverse of P/E).

What was AIOS Tech Inc.'s revenue in fiscal 2025?

AIOS Tech Inc. reported revenue of $5.1M for fiscal 2025, 98.5% lower than the year before.

Was AIOS Tech Inc. profitable in fiscal 2025?

No. It reported a net loss of $220.9M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to AIOS Tech Inc.